Jackson Walker L.L.P. successfully represented Pronto General Agency, Ltd. and its affiliates (“Pronto Insurance”) in a significant investment by Palladium Equity Partners, LLC, a New York City-based private investment firm with over $2.5 billion in assets under management. More >>
Tags: Jackson Walker, LLP | Brownsville | New York
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of AUD 650 million aggregate principal amount of 5% fixed-rate senior registered notes due 2021. The underwriters were Morgan Stanley & Co. International plc, Australia and New Zealand Banking Group Limited, National Australia Bank Limited and Mitsubishi UFJ Securities International plc. More >>
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €1.25 billion aggregate principal amount of 1.875% fixed-rate senior notes due 2023. The lead manager for the underwriters was Morgan Stanley & Co. International plc. More >>
Tags: Davis Polk & Wardwell LLP | New York
Fragomen Worldwide, the world’s leading immigration service provider exclusively devoted to immigration, has further expanded its global presence with the opening of a new office in Nairobi, Kenya.
“As is the case with our new office in Kenya, Fragomen has long been committed to providing on-the-ground service in key international markets that best support our clients’ business goals,” said Austin T. Fragomen, Chairman of the firm’s Executive Committee. “Since opening our first international office in Brussels, we have steadily increased our international reach based on our clients’ needs, and now serve clients in major markets throughout Africa, the Americas, Asia Pacific, Europe and the Middle East.” More >>
Tags: Fragomen, Del Rey, Bernsen & Loewy, LLP | Africa
Dentons has advised Burgan Bank on the issuance of US$500 million Perpetual Tier 1 Capital Securities, which completed on 30 September 2014. The Capital Securities were listed on the Irish Stock Exchange and represented Kuwait’s first ever Basel III-compliant regulatory capital issuance. More >>
Tags: Dentons | DubaiJohnson & Johnson announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. Cravath represented Johnson & Johnson in the transaction. The closing is subject to clearance under the Hart‑Scott‑Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the fourth quarter of 2014. More >>
Tags: New YorkCooley LLP announced today that it advised Horizon Pharma, Inc. on the completion of its acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined to form parent company Horizon Pharma plc, which is incorporated in Ireland. Concurrently with the acquisition, Horizon entered into a five-year $300 million term loan facility and related uncommitted facilities. More >>
Tags: San Diego
Cahill represented Citigroup as sole-underwriter in connection with the secondary public offering of 17,500,000 shares of common stock by certain selling shareholders of Envision Healthcare Holdings, Inc. (NYSE: EVHC) , resulting in gross proceeds of $611,975,000. More >>
Tags: Cahill Gordon & Reindel LLP | New YorkAlston & Bird client Einstein Noah Restaurant Group has entered into a definitive agreement to be acquired by JAB Holding Company, a German conglomerate, for about $374 million.
Based in Lakewood, CO, Einstein Noah operates, franchises and licenses more than 855 restaurants in 42 states and Washington, D.C. Its bagel shops include Einstein Brothers Bagels, Noah’s New York Bagels and Manhattan Bagel. More >>
Tags: Atlanta | Charlotte | Washington
The Firm recently represented Deutsche Bank, J.P. Morgan, MUFG and Credit Suisse as bookrunners for a $5.75 billion offering by Roche Holdings, Inc. of notes, guaranteed by Roche Holding Ltd. The offering consisted of six series of notes, including three-year and five-year floating rate notes and three-year, five-year, seven-year, and ten-year fixed rate notes. The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933. The proceeds of the offering were used for general corporate purposes, including the funding of Roche’s tender offer for the shares of Intermune, Inc. More >>
Tags: Simpson Thacher & Bartlett LLP | London